MILLER AINE (SVP, DEV & HEAD OF IRE OFFICE) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/24/2025ACC: 0002012524-25-000006
Officer· SVP, DEV & HEAD OF IRE OFFICE
Since Feb 2026
-6.99K
Net shares
Net seller
$125.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
6.99K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−6.99K
Price / share
$17.90
Trade value
$125.10K
% of position
3.4%
11/20/2025
208K→201.01K
Total
Net shares
−6.99K
Net value
-$125.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/20/2025 | F · Tax Withholding | −6.99K | $17.90 | $125.10K | 3.4% | 208K | 201.01K |
| Total | −6.99K | -$125.10K | ||||||
Derivative Transactions0
No derivative transactions reported